Istanbul Medical Journal is a prominent open-access journal published by GALENOS PUBL HOUSE, dedicated to disseminating high-quality research in the field of medicine since its inception in 1994. The journal, identifiable by its ISSN 2619-9793 and E-ISSN 2148-094X, serves as a critical platform for healthcare professionals, researchers, and students who aim to share innovative studies and advancements within diverse medical domains. Its commitment to open access ensures that crucial findings and discussions are readily available to a global audience, fostering collaboration and knowledge exchange among the scientific community. Located in Istanbul, Türkiye, the journal not only contributes to the medical literature landscape but also emphasizes the importance of accessibility in research, aligning with current academic trends that prioritize the transmission of knowledge across barriers. As a resource for those involved in healthcare and medical research, the Istanbul Medical Journal plays a vital role in shaping future developments in medicine.

HEALTH TECHNOLOGY ASSESSMENT is a prestigious open-access journal published by the NIHR Journals Library, focusing on advancing the science of health technology assessment through robust research and critical analysis in the fields of Health Policy and Medicine. Since its inception in 2001, this journal has fostered a multidisciplinary approach to evaluating health technologies, offering invaluable insights to researchers, healthcare professionals, and policymakers. With an impressive Q1 ranking in both Health Policy and Medicine (miscellaneous) for 2023, it stands at the forefront of academic discourse, reflecting a high-impact factor and an esteemed reputation within its respective categories. The journal not only publishes original research articles, but also reviews and case studies that illuminate the complexities of health technology in real-world applications. Established and based in the United Kingdom, HEALTH TECHNOLOGY ASSESSMENT strives to encourage evidence-based decision-making, making it an essential resource for anyone committed to enhancing healthcare outcomes through innovative technology assessments.

The Journal of Pharmacy and Bioallied Sciences is a premier open access publication that has been contributing to the fields of Pharmacy, Bioengineering, and Biochemistry since its establishment in India, under the esteemed Wolters Kluwer Medknow Publications. With the ISSN 0976-4879 and E-ISSN 0975-7406, this journal provides a platform for high-quality research articles, reviews, and clinical studies aimed at advancing knowledge and practice in the pharmaceutical and allied sciences. As a reflection of its academic stature, the journal holds a respectable categorization within the third and fourth quartiles in pertinent fields according to the latest metrics, with rankings that place it among prominent emerging research in pharmacology and biochemistry. Researchers and professionals are encouraged to access a wealth of knowledge freely, as the journal has been open access since 2010. The journal not only aims to foster innovative research but also strives to bridge the gap between pharmaceutical sciences and real-world applications, making it an essential resource for students, academics, and industry experts alike.

Pragmatic and Observational Research, published by DOVE MEDICAL PRESS LTD, is a distinguished open-access journal that has been advancing knowledge in the fields of clinical practices and epidemiological studies since its inception in 2010. With an ISSN of 1179-7266, this journal serves as a vital platform for researchers, healthcare professionals, and students to disseminate and access high-quality research that influences real-world health outcomes. Although the journal does not currently have an HIndex or Scopus ranking, its commitment to open access ensures that all articles are readily available to a global audience, facilitating broad engagement and collaboration. The journal focuses on pragmatic and observational methodologies, emphasizing studies that inform evidence-based practices in health care, thereby playing a crucial role in aligning research with practical health challenges. By contributing to the understanding of health interventions and observational data, Pragmatic and Observational Research continues to uphold its mission of improving health care through rigorous research.

Renewable Energy Research and Applications is an esteemed academic journal published by Shahroud University of Technology, dedicated to advancing the field of renewable energy and its diverse applications. Since its inception in 2020, this Open Access journal has provided a platform for publishing innovative research that addresses the critical challenges and opportunities within the renewable energy sector, including solar, wind, hydro, and biomass energy. With an ISSN of 2717-252X and an E-ISSN of 2676-7430, the journal aims to disseminate high-quality research findings that inform policy makers, researchers, and practitioners worldwide. By fostering collaboration and knowledge exchange, the journal plays a vital role in the ongoing transition towards sustainable energy solutions, making it an essential resource for anyone committed to this urgent global challenge.

Rehabilitation Process and Outcome, published by SAGE Publications Ltd, is a premier peer-reviewed journal dedicated to advancing the field of rehabilitation science. With an ISSN of 1179-5727 and an E-ISSN of 1179-5727, this open-access journal has been committed to disseminating high-quality research since its inception in 2008. The journal provides a vital platform for researchers, clinicians, and practitioners to share innovative studies, clinical practices, and advancements in rehabilitation methodologies. Its emphasis on open access ensures that findings are readily available to a global audience, promoting collaboration and knowledge exchange in the rehabilitation community. Rainier emphasis on practical outcomes supports the journal's mission to enhance patient care and recovery processes. Based in London, England, Rehabilitation Process and Outcome continues to foster significant discourse in the rehabilitation sector, making it an essential resource for those involved in enhancing recovery strategies and overall health outcomes.

International Health, published by Oxford University Press, is a leading peer-reviewed journal dedicated to the exploration and advancement of health and healthcare practices across the globe. With its ISSN 1876-3413 and E-ISSN 1876-3405, the journal focuses on a wide variety of topics within the realm of international health, catering to a diverse audience of researchers, professionals, and students. It currently holds a prestigious position in the 2023 quartile rankings, being categorized as Q1 in Health (Social Science) and Q2 in both Medicine (Miscellaneous) and Public Health, Environmental and Occupational Health, reflecting its significant impact within these fields. Although the journal is not open access, it remains a valuable resource, providing crucial insights and fostering discussion around health systems, public policy, and global health challenges from 2009 to 2024. With a strong emphasis on empirical research and innovative practices, International Health serves as a vital platform for knowledge dissemination and scholarly discourse, making substantial contributions to the field of public health worldwide.

BMJ Innovations, published by the esteemed BMJ Publishing Group, serves as a vital platform for advancing the field of medical innovation. Established in 2015, this peer-reviewed journal has quickly gained recognition, currently holding a Q3 ranking in the miscellaneous Medicine category with a notable Scopus rank of #123 out of 636, placing it in the top 20% of its field. With a focus on disseminating groundbreaking research, clinical practices, and case studies that drive innovation in healthcare, BMJ Innovations aims to bridge the gap between theory and practical application, appealing to researchers, healthcare professionals, and students. The journal not only provides significant insights into emerging medical technologies and methodologies but also engages with the ongoing discourse in medicine, shaping the future of patient care. Although it does not follow an Open Access model, access options are available to ensure wide dissemination of its impactful content. The journal's commitment to excellence and contribution to the evolving medical landscape underscores its importance as a hub for innovative thinking in the UK and beyond.

Therapeutic Innovation & Regulatory Science, published by Springer Heidelberg, is an esteemed journal that focuses on the intersection of therapeutic innovations and the regulatory frameworks that govern them. Established in 1970 and continuing its legacy of excellence through converged years, this journal plays a crucial role in supplying cutting-edge research, reviews, and discussions that advance understanding in the fields of pharmacology and healthcare regulation. With an impact factor reflective of its rigorous peer-review standards, this journal holds a prestigious Q1 ranking in Pharmacology, Toxicology, and Pharmaceutics (Miscellaneous) for 2023, reflecting its influence and the high quality of its published material. The journal's wide scope also embraces public health and environmental studies, making it an essential resource for researchers and professionals navigating these critical areas. Open access options enhance its visibility and accessibility, ensuring that the latest discoveries and regulatory insights are readily available to a global audience. For those at the forefront of medicinal science and regulatory affairs, Therapeutic Innovation & Regulatory Science is your avenue to understanding pivotal innovations that shape contemporary therapeutic practices.

PANMINERVA MEDICA is a distinguished journal published by EDIZIONI MINERVA MEDICA, focusing on the multifaceted field of medicine since its inception in 1959. With an ISSN of 0031-0808 and an E-ISSN of 1827-1898, this journal is esteemed for its rigorous peer-review process and its contribution to clinical and experimental research across various domains of medicine. Based in Italy, it holds a commendable position in the 2023 Scopus rankings, where it is placed in the 84th percentile among general medicine journals, highlighting its relevance and scholarly impact. As a Q3 category journal in the medicine (miscellaneous) quartiles, PANMINERVA MEDICA is committed to disseminating high-quality research, fostering scientific dialogue, and advancing medical knowledge globally. While currently not offering open access, it serves as a vital resource for researchers, practitioners, and students seeking to stay at the forefront of medical advancements. The journal is poised to continue its tradition of excellence as it converges into 2024, ensuring robust discourse in healthcare and clinical practices.